Makati has the highest concentration of hospital pharmacies of any district in the country, and for retatrutide specifically that counts for nothing. This trips up new arrivals constantly. They reason, correctly, that Makati Medical Center reliably fills GLP-1 prescriptions and that the Mercury Drug branches along Ayala are the most consistently stocked in the Philippines, and they assume retatrutide sits somewhere on that shelf.
It does not, and it cannot. The compound is still in Eli Lilly Phase 3 trials. There is no approved product in any country, so there is nothing for FDA Philippines to have registered and nothing for an endocrinologist to prescribe. Every retatrutide protocol running in this district is research-grade material in a lyophilized vial.
What Makati genuinely offers is the clinical wraparound. The wellness and longevity clinic cluster along Salcedo Village and Legazpi Village is the deepest in the country, and a consult with a peptide-experienced MD runs PHP 4,500 to 8,000. Bloodwork at Hi-Precision or Healthway runs PHP 3,500 to 5,500. Neither of those produces a prescription. Both of them produce information, which for a compound whose Phase 2 ladder climbed from 2mg weekly to an 8 to 12mg maintenance band is the more useful purchase.
For the hospital and clinic landscape across the district generally, our Makati city guide covers it properly.